Pretreatment with Mangafodipir Improves Liver Graft Tolerance to Ischemia/Reperfusion Injury in Rat

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Ben Mosbah, Ismail ^a,b   Mouchel, Yann ^a,b   Pajaud, Julie ^a,b   Ribault, Catherine ^a,b   Lucas, Catherine ^a   Laurent, Alexis ^c,d   Boudjema, Karim ^a,b   Morel, Fabrice ^a,b   Corlu, Anne ^a,b   Compagnon, Philippe ^a,e  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BILE ACID; CATALASE; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGAFODIPIR; NITRIC OXIDE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG SAFETY; ENDOTHELIUM INJURY; ENZYME ACTIVITY; EX VIVO STUDY; LIPID PEROXIDATION; LIVER GRAFT; LIVER INJURY; LIVER ISCHEMIA; LIVER MITOCHONDRION; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CATALASE; EDETIC ACID; GENE EXPRESSION; GRAFT SURVIVAL; HEME OXYGENASE-1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPID PEROXIDATION; LIVER; LIVER TRANSPLANTATION; MALE; NITRIC OXIDE SYNTHASE; ORGAN CULTURE TECHNIQUES; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PRIMARY GRAFT DYSFUNCTION; PYRIDOXAL PHOSPHATE; RATS; REACTIVE OXYGEN SPECIES; TRANSPLANTATION TOLERANCE;

RATTUS;

EID: 84870612137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050235     Document Type: Article

References (60)

1. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, et al. (2005) Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 241: 905-916; discussion 916-908.
2. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR, (1998) Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 66: 302-310.
3. Chen H, Peng CH, Shen BY, Deng XX, Shen C, et al. (2007) Multi-factor analysis of initial poor graft function after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int 6: 141-146.
4. Markmann JF, Markowitz JS, Yersiz H, Morrisey M, Farmer DG, et al. (1997) Long-term survival after retransplantation of the liver. Ann Surg 226: 408-418; discussion 418-420.
5. Clavien PA, Harvey PR, Strasberg SM, (1992) Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53: 957-978.
6. Jaeschke H, (1996) Preservation injury: mechanisms, prevention and consequences. J Hepatol 25: 774-780.
7. Busuttil RW, Tanaka K, (2003) The utility of marginal donors in liver transplantation. Liver Transpl 9: 651-663.
8. Casillas-Ramirez A, Mosbah IB, Ramalho F, Rosello-Catafau J, Peralta C, (2006) Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79: 1881-1894.
9. Jaeschke H, (2011) Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts. J Gastroenterol Hepatol 26 Suppl 1: 173-179.
10. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM, (2005) The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 11: 1031-1047.
11. Chen C, Johnston TD, Wu G, Ranjan D, (2006) Curcumin has potent liver preservation properties in an isolated perfusion model. Transplantation 82: 931-937.
12. Vairetti M, Ferrigno A, Bertone R, Richelmi P, Berte F, et al. (2005) Apoptosis vs. necrosis: glutathione-mediated cell death during rewarming of rat hepatocytes. Biochim Biophys Acta 1740: 367-374.
13. Ben Mosbah I, Massip-Salcedo M, Fernandez-Monteiro I, Xaus C, Bartrons R, et al. (2007) Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers. Liver Transpl 13: 410-425.
14. Todo S, Hamada N, Zhu Y, Zhang S, Subbotin V, et al. (1996) Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation 61: 189-194.
15. Maeda T, Murase N, Subbotin V, Sakamoto T, Yamada T, et al. (1998) Analogs of cyclic nucleotides in rat liver preservation. Transplantation 66: 844-851.
16. Nakano H, Kuzume M, Namatame K, Yamaguchi M, Kumada K, (1995) Efficacy of intraportal injection of anti-ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am J Surg 170: 64-66.
17. Steib A, Freys G, Collin F, Launoy A, Mark G, et al. (1998) Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation? Liver Transpl Surg 4: 152-157.
18. Mizoe A, Kondo S, Azuma T, Fujioka H, Tanaka K, et al. (1997) Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation. J Surg Res 73: 160-165.
19. Bedda S, Laurent A, Conti F, Chereau C, Tran A, et al. (2003) Mangafodipir prevents liver injury induced by acetaminophen in the mouse. J Hepatol 39: 765-772.
20. Brurok H, Ardenkjaer-Larsen JH, Hansson G, Skarra S, Berg K, et al. (1999) Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? Biochem Biophys Res Commun 254: 768-772.
21. Elizondo G, Fretz CJ, Stark DD, Rocklage SM, Quay SC, et al. (1991) Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178: 73-78.
22. Karlsson JO, Brurok H, Eriksen M, Towart R, Toft KG, et al. (2001) Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol 42: 540-547.
23. Coriat R, Leconte M, Kavian N, Bedda S, Nicco C, et al. (2011) Mangafodipir protects against hepatic ischemia-reperfusion injury in mice. PLoS One 6: e27005.
24. Laskar A, Miah S, Andersson RG, Li W, (2010) Prevention of 7beta-hydroxycholesterol-induced cell death by mangafodipir is mediated through lysosomal and mitochondrial pathways. Eur J Pharmacol 640: 124-128.
25. Bessems M, t Hart NA, Tolba R, Doorschodt BM, Leuvenink HG, et al. (2006) The isolated perfused rat liver: standardization of a time-honoured model. Lab Anim 40: 236-246.
26. Jynge P, Brurok H, Asplund A, Towart R, Refsum H, et al. (1997) Cardiovascular safety of MnDPDP and MnCl2. Acta Radiol 38: 740-749.
27. Ben Mosbah I, Rosello-Catafau J, Alfany-Fernandez I, Rimola A, Parellada PP, et al. (2010) Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. Liver Transpl 16: 163-171.
28. Compagnon P, Clement B, Campion JP, Boudjema K, (2001) Effects of hypothermic machine perfusion on rat liver function depending on the route of perfusion. Transplantation 72: 606-614.
29. Minor T, Akbar S, Tolba R, Dombrowski F, (2000) Cold preservation of fatty liver grafts: prevention of functional and ultrastructural impairments by venous oxygen persufflation. J Hepatol 32: 105-111.
30. Nakagami M, Morimoto T, Mitsuyoshi A, Mashima S, Shimabukuro T, et al. (1996) Difference in onset of warm ischemia and reperfusion injury between parenchymal and endothelial cells of the liver. Evaluation by purine nucleoside phosphorylase and hyaluronic acid. J Surg Res 62: 118-124.
31. Ben Mosbah I, Alfany-Fernandez I, Martel C, Zaouali MA, Bintanel-Morcillo M, et al. (2010) Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis 1: e52.
32. t Hart NA, van der Plaats A, Leuvenink HG, Wiersema-Buist J, Olinga P, et al. (2004) Initial blood washout during organ procurement determines liver injury and function after preservation and reperfusion. Am J Transplant 4: 1836-1844.
33. Jaeschke H, (2000) Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 15: 718-724.
34. Jamieson NV, Sundberg R, Lindell S, Southard JH, Belzer FO, (1988) A comparison of cold storage solutions for hepatic preservation using the isolated perfused rabbit liver. Cryobiology 25: 300-310.
35. Gores GJ, Herman B, Lemasters JJ, (1990) Plasma membrane bleb formation and rupture: a common feature of hepatocellular injury. Hepatology 11: 690-698.
36. Orii T, Ohkohchi N, Satomi S, Taguchi Y, Mori S, et al. (1992) Assessment of liver graft function after cold preservation using 31P and 23Na magnetic resonance spectroscopy. Transplantation 53: 730-734.
37. Nathanson MH, Boyer JL, (1991) Mechanisms and regulation of bile secretion. Hepatology 14: 551-566.
38. Kamiike W, Nakahara M, Nakao K, Koseki M, Nishida T, et al. (1985) Correlation between cellular ATP level and bile excretion in the rat liver. Transplantation 39: 50-55.
39. Dickson RC, Bronk SF, Gores GJ, (1992) Glycine cytoprotection during lethal hepatocellular injury from adenosine triphosphate depletion. Gastroenterology 102: 2098-2107.
40. Jaeschke H, (2003) Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284: G15-26.
41. Gonzalez FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, et al. (1994) Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 20: 565-573.
42. Macmillan-Crow LA, Cruthirds DL, (2001) Invited review: manganese superoxide dismutase in disease. Free Radic Res. Apr 34 (4):: 325-36.
43. Lee SM, Park MJ, Cho TS, Clemens MG, (2000) Hepatic injury and lipid peroxidation during ischemia and reperfusion. Shock 13: 279-284.
44. Alexandre J, Nicco C, Chereau C, Laurent A, Weill B, et al. (2006) Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 98: 236-244.
45. Yabe Y, Nishikawa M, Tamada A, Takakura Y, Hashida M, (1999) Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther 289: 1176-1184.
46. Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, et al. (2006) Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 20: 2624-2626.
47. Premkumar DR, Smith MA, Richey PL, Petersen RB, Castellani R, et al. (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 65 (3):: 1399-1402.
48. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, et al. (1998) Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83: 568-577.
49. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, et al. (1999) Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Investig 104: 1631-1639.
50. Redaelli CA, Tian YH, Schaffner T, Ledermann M, Baer HU, et al. (2002) Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology 35: 1082-1092.
51. Clavien PA, (1998) Sinusoidal endothelial cell injury during hepatic preservation and reperfusion. Hepatology 28: 281-285.
52. Ikeda A, Ueki S, Nakao A, Tomiyama K, Ross MA, et al. (2009) Liver graft exposure to carbon monoxide during cold storage protects sinusoidal endothelial cells and ameliorates reperfusion injury in rats. Liver Transpl 15: 1458-1468.
53. Asplund A, Grant D, Karlsson JO, (1994) Mangafodipir (MnDPDP)-and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries. J Pharmacol Exp Ther 271: 609-614.
54. Duranski MR, Elrod JW, Calvert JW, Bryan NS, Feelisch M, et al. (2006) Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 291: H2980-2986.
55. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, et al. (2008) The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 45: 18-31.
56. Gao W, Bentley RC, Madden JF, Clavien PA, (1998) Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 27: 1652-1660.
57. Jaeschke H, Gujral JS, Bajt ML, (2004) Apoptosis and necrosis in liver disease. Liver Int 24: 85-89.
58. Liu X, Kim CN, Yang J, Jemmerson R, Wang X, (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
59. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, et al. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50.
60. Skjold A, Amundsen BH, Wiseth R, Stoylen A, Haraldseth O, et al. (2007) Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction. J Magn Reson Imaging 26: 720-727.